IGF1 and Alzheimer disease: Blockade of the interferon signaling in the choroid plexus of aged mice and in the microglia of the AD mouse model decreased inflammation, improved cognitive function and increased hippocampal neurogenesis levels through decreased microgliosis and astrogliosis as well as increased expression of BDNF and IGF, all of which were dependent on type II IFN signaling62,63.